AMN Q4 adjusted diluted EPS falls 70% to USD 0.22

Reuters02-20
AMN Q4 adjusted diluted EPS falls 70% to USD 0.22

AMN Healthcare (AMN) reported Q4 FY2025 revenue of USD 748.2 million (+2% YoY) and a net loss of USD 7.7 million (loss of USD 0.20 per diluted share), with adjusted diluted EPS of USD 0.22 (-70% YoY). Q4 adjusted EBITDA was USD 54.5 million (-27% YoY) and gross margin was 26.1% (down 370 basis points YoY). Operating cash flow was USD 75.57 million in Q4. For FY2025, AMN posted revenue of USD 2.73 billion (-8% YoY) and a net loss of USD 95.7 million (loss of USD 2.48 per diluted share), while adjusted diluted EPS was USD 1.36 (-59% YoY). FY2025 adjusted EBITDA was USD 234.5 million (-31% YoY) and operating cash flow was USD 269.46 million. AMN ended 2025 with USD 33.97 million in cash and cash equivalents and USD 775 million in total debt, after reducing debt by USD 75 million in Q4 and USD 285 million for the year. In Q4, Nurse and Allied Solutions revenue was USD 490.71 million (+8% YoY), including USD 124 million of labor disruption revenue; Physician and Leadership Solutions revenue was USD 169.55 million (-2% YoY); and Technology and Workforce Solutions revenue was USD 87.96 million (-18% YoY). AMN said Q4 results exceeded expectations on better nurse and allied staffing performance, supported by large labor disruption events, with travel nurse volume up 5% sequentially and interim leadership and search returning to sequential revenue growth. For Q1 2026, AMN guided consolidated revenue of USD 1.23 billion to USD 1.24 billion, gross margin of 23.5% to 24.0%, operating margin of 5.9% to 6.5%, and adjusted EBITDA margin of 9.7% to 10.2%, assuming approximately USD 600 million of labor disruption revenue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AMN Healthcare Services Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9657761-en) on February 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment